Atea Pharmaceuticals
AVIR
AVIR
112 hedge funds and large institutions have $220M invested in Atea Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 39 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
112
Holders Change
+5
Holders Change %
+4.67%
% of All Funds
1.62%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
34
Reduced
39
Closed
14
Calls
$494K
Puts
$6.38M
Net Calls
-$5.88M
Net Calls Change
-$6.01M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.73M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.41M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.17M |
| 4 |
Two Sigma Advisers
New York
|
+$1.04M |
| 5 |
Two Sigma Investments
New York
|
+$850K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.43M |
| 2 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$2.56M |
| 3 |
Morgan Stanley
New York
|
-$1.66M |
| 4 |
Renaissance Technologies
New York
|
-$1.51M |
| 5 |
BlackRock
New York
|
-$810K |